Company Profile

Profile last edited on: 1/24/21      CAGE: 7HK15      UEI: J3MJMP8VCF75

Business Identifier: Regenerative medicine technologies to advance human and veterinary health
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10203 SW 49th Lane
Gainesville, FL 32608
   (239) 464-6713
Location: Single
Congr. District: 03
County: Alachua

Public Profile

Spun out of the University of Florida, 42Bio’s mission is to develop and implement regenerative medicine technologies to advance human and veterinary health. The objective of 42Bio is to apply magnetic and biomolecule technologies to address unmet needs in clinical and veterinary disease and injury. The firm's technologies in development include a magnetic separation system for purification of SARS-CoV-2 therapeutic antibodies, a unique biomolecule extraction from the placenta for regenerative medicine applications, and magnetic separation for the isolation of stem cells from cord tissue for research applications

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NSF $255,993
Project Title: Immunity Transfer by Magnetic Separation (COVID-19)

Key People / Management

  Isaac Finger-Baker -- VP of Product Development

Company News

There are no news available.